Match the claim to the people studied
Ask who participated, their condition, and whether those participants resemble the people addressed by the claim. A result in one diagnosis or age group cannot automatically be generalized to another. NCCIH's condition-by-condition evidence summaries illustrate why population and indication matter.
Check the exact product and comparison
Check which cannabinoid, formulation, route, amount, and comparison were used. A study of a regulated prescription medicine does not establish effects for a retail oil, edible, or topical with a different composition.
Look for meaningful outcomes and harms
Look beyond a headline: how many participants completed the study, what outcome changed, by how much, and over what period? Were adverse events or dropouts reported? NCCIH notes one chronic-pain review's difference may be too small to matter to patients; CDC says evidence is limited for most pain types.
Separate "studied" from "authorized"
FDA approval applies to particular products and indications; being studied or sold does not itself mean a health claim is authorized. Testimonials and a link to one paper cannot answer these questions. This checklist is educational, not treatment advice. See chronic-pain evidence context.
Quick FAQ
Does one positive study prove a cannabis product works?
No. Match the condition, product, study design, comparison, outcomes, and limitations; one study does not establish general efficacy.
Are cannabis products automatically FDA-approved medicines?
No. FDA approval applies to specific medicines and indications, not every cannabis product or health claim.
What should I check first in a cited study?
Start with whether the population, diagnosis, product, and outcome match the claim being made.
Sources
- NIH NCCIH -- Directly readable 2026-09-25; condition-specific evidence summaries show different findings and study limitations.
- FDA -- Directly readable 2026-09-25; explains FDA role and specific approved cannabinoid medicines; no blanket endorsement.
- CDC -- Directly readable 2026-09-25; example of cautious, condition-specific evidence limits.
Sources checked 2026-09-25; verify current official guidance before acting.